DLBCL
Conditions
Interventions
Trial group:NA
Sponsors
Cancer Hospital Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old, male or female; 2. Patients with histologically or cytologically confirmed DLBCL (including DLBCL NOS, CLL-transformed DLBCL, indolent lymphoma-transformed DLBCL, and HGBL with double/triple blows). 3. There are sufficient tumor FFPE samples or retained tissue white films, and the subsequent routine diagnosis and treatment of patients should not be affected after the samples are removed or the retained white films are used; 4. The sample should be biopsy tissue from the time of initial diagnosis of DLBCL. If the patient re-undergoes biopsy when the disease recurs or progresses, it can also be sent for testing as appropriate; Each case should have at least the biopsy tissue from the time of initial diagnosis; 5. Have relatively complete diagnosis and treatment information of our hospital (including baseline characteristics, treatment plan, efficacy evaluation and other data).
Exclusion criteria
Exclusion criteria: 1. There are no patients with biopsy tissue samples or blank films at the time of initial diagnosis of DLBCL; 2. Patients with incomplete diagnosis and treatment information records in the HIS system, which affects the analysis of clinical information; 3. Diseases other than DLBCL diagnosis; 4. Patients who are considered by other investigators to be unsuitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ROR1 Positivity rate;ROR1 H-score; | — |
Countries
China
Contacts
Public ContactYuankai Shi
Cancer Hospital Chinese Academy of Medical Sciences
Outcome results
None listed